# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T19:34:01.497541
**Route:** OpenRouter + LaTeX
**Tokens:** 19566 in / 1911 out
**Response SHA256:** d3e6c0a85129f954

---

I have reviewed the draft for the specific classes of fatal errors you asked me to check (data-design alignment, regression sanity, completeness, internal consistency). I found no fatal errors in the manuscript as presented.

Notes on scope: I checked the LaTeX source and all substantive claims that could produce a fatal inconsistency across the paper (treatment timing vs. data coverage, presence of post-treatment observations, treatment definition consistency, obviously broken regression outputs or impossible reported statistics, placeholders/missing results, and internal consistency of numbers and timing statements). I did not review prose quality, contribution/novelty, or minor modeling choices.

Findings (summary)
- Data–design alignment: Consistent. The paper clearly states data span (NCHS 1999–2017 + provisional 2020–2023), and treatment cohorts are restricted so that first_treat ≤ 2023 for the treated group. The manuscript repeatedly documents that states with first treatment year >2023 are treated-as-not-yet-treated, and Vermont (treated 2022) is excluded due to suppression; these reclassifications are described consistently across sections.
- Regression sanity: I found no manifestly impossible or internally inconsistent statistics in the text. (All reported descriptive numbers—mean mortality ≈ 22 per 100,000; SD ≈ 7; 17 treated states with first treatment ≤2023; 34 controls—are plausible and mutually consistent in the narrative.) The manuscript reports use of cluster-robust SEs, bootstrap inference, and modern DiD estimators; no tables in the LaTeX source contain explicit placeholders like "NA", "TBD", "XXX", or impossible numeric values visible in the source.
- Completeness: The draft contains all required elements for an empirical paper: data description, policy coding, sample construction, main regression approach, robustness checks, event study, placebo tests, sensitivity analyses, and an appendix describing data construction and code/packages. There are no visible placeholder tokens or missing figure/table references in the main LaTeX file.
- Internal consistency: Treatment timing, sample counts, and the role of suppressed jurisdictions are described in a consistent manner across the main text and appendices. The estimation choices described (Callaway-Sant'Anna with never-treated controls, allowance for unbalanced panel) align with the described data limitations (2018–2019 gap and suppressed post-periods for some small jurisdictions).

Caveats (not fatal errors, but things to confirm before submission)
- I could not examine the contents of the external table files you \input (tables/table1_summary_stats.tex, tables/table2_policy_dates.tex, tables/table3_main_results.tex, tables/table4_robustness.tex, tables/table5_heterogeneity.tex). The LaTeX source references these files; I assume they are present and contain the regression outputs and summary statistics you intended. Before submission, ensure those files contain:
  - No placeholder entries ("NA", "TBD", "XXX") in cells that should contain estimates.
  - Regression tables include sample sizes (N) and report standard errors (or CIs) and cluster information (you state cluster-robust SEs with small-sample correction).
  - R² values (if reported) are within [0,1].
  - No extremely large or implausible coefficients or SEs (e.g., SEs >>100 or SEs >> 100×|coef|) — I could not verify numeric magnitudes inside the external files from the main .tex alone.
- Reproducibility assets: you cite a project repository URL. Make sure the repository includes the external table files and code used to generate figures and tables; journals often check that.
- Minor textual clarity (not fatal): some wording around the 2018–2019 gap and the panel assembly is slightly confusing (you correctly treat 1999–2017 and 2020–2023 as the available years, but some sentences imply dropping the gap later). This is a clarity issue, not a fatal data-design mismatch.

Final determination
Because I did not find any fatal errors in the categories you asked me to screen for, the paper passes this advisor-level check and can proceed to journal referee review.

ADVISOR VERDICT: PASS